Return to Listing

1 result(s) for

PI Name Protocol # Title
Zahi Mitri STUDY00019358 Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients with ER+/HER2- Advanced Breast Cancer following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-Label, Active-Controlled, Multicenter Trial (EMERALD)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080